Royalcare Super Speciality Hospitals Unlisted Share Price
As of , the indicative unlisted share price of Royalcare Super Speciality Hospitals is ₹160 per share. This is an over-the-counter reference price, not a stock-exchange quote.
As of , Royalcare Super Speciality Hospitals is not listed on any Indian stock exchange (NSE or BSE) — its shares trade in the unlisted, over-the-counter (pre-IPO) market.
| Price / unit | ₹160 |
|---|---|
| Market cap | ₹2,925 Cr |
| Min. investment | ₹10,400 |
| Lot size | 65 |
| P/E ratio | 193.67 |
| P/B ratio | 9.21 |
What is Royalcare Super Speciality Hospitals?
Royalcare Super Speciality Hospitals is an unlisted Healthcare company whose shares trade in India's over-the-counter (pre-IPO) market and settle in demat form (NSDL/CDSL).
Royalcare Super Speciality Hospital Limited is a Coimbatore-based healthcare company that owns and operates a large multi-disciplinary tertiary care hospital in Tamil Nadu. Incorporated in 2012, the company began clinical operations in 2015 and has since scaled into one of the region's prominent ultramodern hospital facilities, with bed capacity that has grown into the several-hundred-bed range as the institution expanded its infrastructure and service lines. The hospital provides care across a broad spread of medical and surgical specialities, including cardiology and cardiothoracic surgery, neurology and neurosurgery, orthopaedics, oncology, nephrology and urology, gastroenterology, and pulmonology, alongside critical care, emergency services, and allied diagnostic departments. This integrated, multi-speciality model positions Royalcare as a referral destination for complex and high-acuity treatment in and around the Coimbatore region of western Tamil Nadu, an area with a sizeable catchment population and growing demand for organised private healthcare. In terms of scale, the company reported revenue of around ₹338 crore for the financial year ended March 2024, supported by steady top-line growth and improving operating profitability over recent years. It has an authorised capital that supports a paid-up equity base of roughly ₹205 crore, with shares carrying a face value of ₹10 each. Registrar and transfer functions are handled by an established RTA, and the shares are admitted in dematerialised form with both depositories, which facilitates off-market transfers. Royalcare draws attention in the unlisted market because it represents a focused, single-asset hospital operator in the structurally expanding Indian private healthcare sector, a theme that has attracted investor interest as several listed hospital chains have demonstrated the long-duration nature of the business. As a public limited company that is not currently listed on the NSE or BSE and has not filed a draft prospectus, its equity changes hands through over-the-counter unlisted-share transactions, where prices are indicative and set by buyer-seller negotiation rather than an exchange order book. The combination of a recognisable regional brand, diversified speciality mix, and pre-listing status keeps it on the radar of participants who track healthcare-sector unlisted opportunities.
Explore more unlisted shares
Other companies in our curated selection.
Frequently asked questions
No. As of 16 July 2026, Royalcare Super Speciality Hospitals is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
The minimum lot is 65 share(s); at the indicative price of about ₹160, that is approximately ₹10,400. Indicative reference, not a quote.
As of 16 July 2026, the indicative unlisted share price of Royalcare Super Speciality Hospitals is ₹160 per share. This is an over-the-counter reference price, not a stock-exchange quote.
Royalcare Super Speciality Hospital Limited operates a large multi-speciality tertiary care hospital in Coimbatore, Tamil Nadu. It offers treatment across specialities such as cardiology, neurology, orthopaedics, oncology, nephrology, urology, gastroenterology and pulmonology, along with critical care, emergency and diagnostic services, serving the western Tamil Nadu region.
No. Royalcare Super Speciality Hospital is currently an unlisted public company and is not traded on the NSE or BSE, and it has not filed a draft prospectus for an IPO. Its shares are held in dematerialised form and change hands through off-market unlisted-share transactions between a willing buyer and seller, settled by transferring shares between demat accounts. This is descriptive information only and not a recommendation to transact.
As an unlisted company, Royalcare has no exchange-quoted price. Its indicative price reflects what buyers and sellers negotiate in the over-the-counter market and is influenced by factors such as the company's reported financials, hospital occupancy and growth, broader sentiment toward the healthcare sector, demand and supply for the stock, and any IPO-related expectations. Indicative prices can vary across sources and over time.
Royalcare Super Speciality Hospital Limited was incorporated in 2012 with its registered office in Coimbatore, Tamil Nadu. Its CIN is U85100TZ2012PLC018984 and ISIN is INE02C801010, with equity shares carrying a face value of ₹10 each. The company reported revenue of around ₹338 crore for FY2024 and operates with a paid-up equity base of approximately ₹205 crore.
They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.
After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.
Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.
Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.
An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.
Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.
Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.
Royalcare Super Speciality Hospitals vs similar unlisted Healthcare shares
Indicative over-the-counter prices, as of 16 July 2026. Information only — not a recommendation or ranking.